Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
10.47
-0.01 (-0.10%)
Apr 16, 2025, 10:23 AM EDT - Market open
Beta Bionics Revenue
In the year 2024, Beta Bionics had annual revenue of $65.12M with 442.93% growth. Beta Bionics had revenue of $20.44M in the quarter ending December 31, 2024.
Revenue (ttm)
$65.12M
Revenue Growth
+442.93%
P/S Ratio
1.02
Revenue / Employee
$221,510
Employees
294
Market Cap
453.86M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 65.12M | 53.13M | 442.93% |
Dec 31, 2023 | 12.00M | 11.82M | 6,601.12% |
Dec 31, 2022 | 179.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBBNX News
- 7 days ago - Beta Bionics to Host Investor Event on June 22, 2025 - GlobeNewsWire
- 19 days ago - Beta Bionics Announces Board Appointment of Gerard Michel - GlobeNewsWire
- 21 days ago - Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025 - GlobeNewsWire
- 6 weeks ago - Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 - GlobeNewsWire
- 2 months ago - Beta Bionics: A Sugar Rush For This IPO - Seeking Alpha
- 2 months ago - U.S. IPO Weekly Recap: Active January Closes Out With Several Sizable IPOs - Seeking Alpha
- 2 months ago - Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 2 months ago - Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering - GlobeNewsWire